Washington Trust Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,353
| Closed | -$310K | – | 209 |
|
|
2024
Q4 | $310K | Buy |
3,353
+5
| +0.1% | +$450 | 0.03% | 175 |
|
|
2024
Q3 | $281K | Hold |
3,348
| – | – | 0.03% | 174 |
|
|
2024
Q2 | $230K | Sell |
3,348
-11
| -0.3% | -$734 | 0.02% | 185 |
|
|
2024
Q1 | $246K | Sell |
3,359
-60
| -2% | -$4.61K | 0.02% | 197 |
|
|
2023
Q4 | $277K | Hold |
3,419
| – | – | 0.02% | 189 |
|
|
2023
Q3 | $256K | Sell |
3,419
-737
| -18% | -$56.7K | 0.03% | 191 |
|
|
2023
Q2 | $320K | Buy |
4,156
+800
| +24% | +$63.8K | 0.03% | 171 |
|
|
2023
Q1 | $278K | Sell |
3,356
-375
| -10% | -$31.1K | 0.03% | 186 |
|
|
2022
Q4 | $321K | Buy |
+3,731
| New | +$295K | 0.04% | 170 |
|
|
2022
Q2 | – | Sell |
-3,781
| Closed | -$225K | – | 228 |
|
|
2022
Q1 | $225K | Sell |
3,781
-11
| -0.3% | -$703 | 0.03% | 206 |
|
|
2021
Q4 | $275K | Sell |
3,792
-3,495
| -48% | -$241K | 0.03% | 191 |
|
|
2021
Q3 | $509K | Buy |
7,287
+3,437
| +89% | +$241K | 0.06% | 120 |
|
|
2021
Q2 | $265K | Sell |
3,850
-95
| -2% | -$6.34K | 0.03% | 152 |
|
|
2021
Q1 | $255K | Buy |
+3,945
| New | +$254K | 0.03% | 154 |
|
|
2019
Q2 | – | Sell |
-2,191
| Closed | -$142K | – | 331 |
|
|
2019
Q1 | $142K | Sell |
2,191
-255
| -10% | -$16.9K | 0.02% | 220 |
|
|
2018
Q4 | $153K | Buy |
2,446
+137
| +6% | +$9.58K | 0.02% | 228 |
|
|
2018
Q3 | $179K | Buy |
2,309
+1,030
| +81% | +$77.8K | 0.03% | 223 |
|
|
2018
Q2 | $90K | Sell |
1,279
-150
| -10% | -$10.6K | 0.01% | 312 |
|
|
2018
Q1 | $108K | Buy |
1,429
+91
| +7% | +$7.23K | 0.02% | 291 |
|
|
2017
Q4 | $95K | Sell |
1,338
-151
| -10% | -$11.5K | 0.01% | 321 |
|
|
2017
Q3 | $121K | Sell |
1,489
-1,278
| -46% | -$97.7K | 0.02% | 280 |
|
|
2017
Q2 | $196K | Buy |
2,767
+550
| +25% | +$36.6K | 0.04% | 199 |
|
|
2017
Q1 | $151K | Sell |
2,217
-821
| -27% | -$57.7K | 0.03% | 229 |
|
|
2016
Q4 | $218K | Sell |
3,038
-794
| -21% | -$59K | 0.05% | 181 |
|
|
2016
Q3 | $303K | Sell |
3,832
-2,270
| -37% | -$184K | 0.07% | 142 |
|
|
2016
Q2 | $509K | Sell |
6,102
-5,359
| -47% | -$476K | 0.13% | 103 |
|
|
2016
Q1 | $1.05M | Sell |
11,461
-431
| -4% | -$38.9K | 0.27% | 70 |
|
|
2015
Q4 | $1.2M | Sell |
11,892
-289
| -2% | -$30.1K | 0.26% | 72 |
|
|
2015
Q3 | $1.2M | Buy |
12,181
+312
| +3% | +$34.7K | 0.32% | 68 |
|
|
2015
Q2 | $1.39M | Sell |
11,869
-667
| -5% | -$72.9K | 0.34% | 61 |
|
|
2015
Q1 | $1.23M | Buy |
12,536
+2,454
| +24% | +$249K | 0.3% | 74 |
|
|
2014
Q4 | $950K | Sell |
10,082
-321
| -3% | -$33.2K | 0.25% | 91 |
|
|
2014
Q3 | $1.11M | Sell |
10,403
-693
| -6% | -$67.9K | 0.35% | 77 |
|
|
2014
Q2 | $920K | Buy |
11,096
+1,367
| +14% | +$106K | 0.19% | 94 |
|
|
2014
Q1 | $689K | Buy |
+9,729
| New | +$763K | 0.15% | 105 |
|
Other funds holding GILD
Washington Trust Bank's GILD Position: Q1 2025 in Review
Washington Trust Bank sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 3,353 shares — an estimated $310K sold.
Washington Trust Bank first reported a position in GILD in Q1 2014 and held it in 35 quarters. The position peaked at $1.39M in Q2 2015. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Washington Trust Bank reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Washington Trust Bank sold 3,353 Gilead Sciences shares in Q1 2025, an estimated $310K.
- Washington Trust Bank first reported a position in Gilead Sciences in Q1 2014 and held it in 35 quarters.
- Washington Trust Bank's Gilead Sciences position peaked at $1.39M in Q2 2015.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Washington Trust Bank's 13F filing for Q1 2025, filed 30 Apr 2025.